Elis has been given a Buy rating by UBS, with a target price of €27. The investment bank's decision is based on the company's resilience and strong leadership.
UBS believes that Elis's ongoing deleveraging process positions it well for potential returns to shareholders and opportunities for external growth through mergers and acquisitions. This positive outlook reflects confidence in Elis's ability to navigate market challenges and enhance shareholder value.
The recommendation is part of a broader focus on companies with solid fundamentals and strategic growth potential.